Finance

Beta
Lists
CNTX:NASDAQ
Context Therapeutics Inc
0,63 US$
+5,32%
(+0,032) 1D
0,62 US$
-1,88% (-0,012)
Pre-market
Closed: 18 ივნ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNTX...
Open
0,62 US$
High
0,64 US$
Low
0,59 US$
Mkt. cap
58,06 მლნ.
Avg. vol.
1,71 მლნ.
Volume
0,00
52-wk high
3,62 US$
52-wk low
0,56 US$
EPS
-0,42 US$
Beta
1,61
Shares outstanding
91,88 მლნ.
No. of employees
15
Open
0,62 US$
High
0,64 US$
Low
0,59 US$
Mkt. cap
58,06 მლნ.
Avg. vol.
1,71 მლნ.
Volume
0,00
52-wk high
3,62 US$
52-wk low
0,56 US$
EPS
-0,42 US$
Beta
1,61
Shares outstanding
91,88 მლნ.
No. of employees
15
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to CNTX in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CNTX in the last 3 months.
Highest
Current 0,63 US$
7,00 US$ (+1 007,77%)
Average
5,67 US$ (+797,29%)
Lowest
4,00 US$ (+533,01%)
News stories
From sources across the web
The Korea Herald
The Korea Herald
·
41 წუთის წინ
SK hynix seeks AI premium with Nasdaq listing
www.marketscreener.com
www.marketscreener.com
·
1 საათის წინ
Nasdaq-listed tech company MKS opens $94mn centre in Malaysia
Investor's Business Daily
Investor's Business Daily
·
2 საათის წინ
Dow Jones Futures Fall After U.S.-Iran Talks; Nvidia, SpaceX, Micron In Focus
About Context Therapeutics Inc
CEO-
Employees15
Founded2015
Headquartersფილადელფია, პენსილვანია, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,83 მლნ.
8,72 მლნ.
11,84 მლნ.
7,02 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,93 მლნ.
1,89 მლნ.
1,96 მლნ.
2,33 მლნ.
Operating expense
9,76 მლნ.
10,61 მლნ.
13,80 მლნ.
9,34 მლნ.
Total operating expenses
9,76 მლნ.
10,61 მლნ.
13,80 მლნ.
9,34 მლნ.
Operating income
-9,76 მლნ.
-10,61 მლნ.
-13,80 მლნ.
-9,34 მლნ.
Other non operating income
27,08 ათ.
83,47 ათ.
96,56 ათ.
-
EBT including unusual items
-8,83 მლნ.
-9,69 მლნ.
-13,03 მლნ.
-8,68 მლნ.
EBT excluding unusual items
-8,83 მლნ.
-9,69 მლნ.
-13,03 მლნ.
-8,68 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,83 მლნ.
-9,69 მლნ.
-13,03 მლნ.
-8,68 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,09
-0,10
-0,14
-0,09
Interest and investment income
903,77 ათ.
833,77 ათ.
682,48 ათ.
520,14 ათ.
Interest expense
-
-
-
-
Net interest expenses
903,77 ათ.
833,77 ათ.
682,48 ათ.
520,14 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,75 მლნ.
-10,61 მლნ.
-13,80 მლნ.
-9,34 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more